Timotej Šúri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Timotej Šúri has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Alexander Nagy
National Institute of Public Health, Prague, Czech Republic
2 shared publicationsHelena Jiřincová
National Institute of Public Health, Prague, Czech Republic
2 shared publications- Jan Pačes
Institute of Molecular Genetics of the Czech Academy of Sciences, 14220 Prague, Czech Republic
2 shared publications Jan Svatoň
University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
2 shared publicationsKarel Berka
Department of Physical Chemistry, Faculty of Science, Palacký University in Olomouc, Olomouc, Czech Republic
2 shared publicationsLucie Pfeiferová
Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czech Republic
2 shared publications
Latest Publications
- Open Access
- 4 June 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 19690
Developing molecular surveillance of SARS-CoV-2 in the Czech Republic (2021–2022)
Molecular surveillance was widely used during the COVID-19 pandemic to detect rapidly emerging variants and monitor the transmission of SARS-CoV-2 within communities. In 2021, the Czech COVID-19 Genomics Consortium (COG-CZ) was set up to coordinate a new SARS-CoV-2 molecular surveillance network. In the Czech Republic, molecular surveillance employed whole genome sequencing (WGS) and variant discrimination polymerase chain reaction (VD-PCR) on samples collected through passive, active and sentinel surveillance. All WGS data was uploaded to GISAID and the PANGO lineages used by GISAID were compared to the main variants determined by VD-PCR. To assess the effectiveness and reliability of the gathered data in adapting pandemic responses, the capabilities and turnaround times of the molecular surveillance methods are evaluated. VD-PCR results were available within 48 h of sample collection for 81.5% of cases during the Delta/Omicron transition. WGS enabled the detection of low-frequency novel variants in infection clusters. WGS surveillance showed there was community spread of AY.20.1, a variant that gained novel mutations within the Czech Republic. Molecular surveillance informed the implementation of public health measures; temporal comparisons of restrictions and outcomes are described. Further areas for improvement have been identified for monitoring and managing future pandemics.
- 4 June 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 19690
Open AccessDeveloping molecular surveillance of SARS-CoV-2 in the Czech Republic (2021–2022)
Molecular surveillance was widely used during the COVID-19 pandemic to detect rapidly emerging variants and monitor the transmission of SARS-CoV-2 within communities. In 2021, the Czech COVID-19 Genomics Consortium (COG-CZ) was set up to coordinate a new SARS-CoV-2 molecular surveillance network. In the Czech Republic, molecular surveillance employed whole genome sequencing (WGS) and variant discrimination polymerase chain reaction (VD-PCR) on samples collected through passive, active and sentinel surveillance. All WGS data was uploaded to GISAID and the PANGO lineages used by GISAID were compared to the main variants determined by VD-PCR. To assess the effectiveness and reliability of the gathered data in adapting pandemic responses, the capabilities and turnaround times of the molecular surveillance methods are evaluated. VD-PCR results were available within 48 h of sample collection for 81.5% of cases during the Delta/Omicron transition. WGS enabled the detection of low-frequency novel variants in infection clusters. WGS surveillance showed there was community spread of AY.20.1, a variant that gained novel mutations within the Czech Republic. Molecular surveillance informed the implementation of public health measures; temporal comparisons of restrictions and outcomes are described. Further areas for improvement have been identified for monitoring and managing future pandemics.
- Open Access
- 5 April 2024
- Published by Springer Nature in Research Square
Developing molecular surveillance of SARS-CoV-2 in the Czech Republic (2021–2022)
Molecular surveillance was widely used during the COVID-19 pandemic to rapidly detect emerging variants and monitor the transmission of SARS-CoV-2 within communities. In 2021, the Czech COVID-19 Genomics Consortium (COG-CZ) was set up to coordinate a new SARS-CoV-2 molecular surveillance network. In the Czech Republic, molecular surveillance employed whole genome sequencing (WGS) and variant discrimination polymerase chain reaction (VD-PCR) on samples collected through passive, active and sentinel surveillance. All WGS data was uploaded to GISAID and the PANGO lineages used by GISAID were compared to the main variants determined by VD-PCR. To assess the effectiveness and reliability of the gathered data in adapting pandemic responses, the capabilities and turnaround times of the molecular surveillance methods are evaluated.VD-PCR enabled accurate detection of changes in major variant dominance within 48 h of sample collection during the Delta/Omicron transition. WGS detected novel mutations and infection clusters, including several genetic lineages and clades of the virus, some of which were unique to the Czech Republic, such as AY.20.1. Molecular surveillance informed the implementation of public health measures and contributed to reduced cases and mortality, however further areas for improvement have been identified for monitoring and managing future pandemics.
- 5 April 2024
- Published by Springer Nature in Research Square
Open AccessDeveloping molecular surveillance of SARS-CoV-2 in the Czech Republic (2021–2022)
Molecular surveillance was widely used during the COVID-19 pandemic to rapidly detect emerging variants and monitor the transmission of SARS-CoV-2 within communities. In 2021, the Czech COVID-19 Genomics Consortium (COG-CZ) was set up to coordinate a new SARS-CoV-2 molecular surveillance network. In the Czech Republic, molecular surveillance employed whole genome sequencing (WGS) and variant discrimination polymerase chain reaction (VD-PCR) on samples collected through passive, active and sentinel surveillance. All WGS data was uploaded to GISAID and the PANGO lineages used by GISAID were compared to the main variants determined by VD-PCR. To assess the effectiveness and reliability of the gathered data in adapting pandemic responses, the capabilities and turnaround times of the molecular surveillance methods are evaluated.VD-PCR enabled accurate detection of changes in major variant dominance within 48 h of sample collection during the Delta/Omicron transition. WGS detected novel mutations and infection clusters, including several genetic lineages and clades of the virus, some of which were unique to the Czech Republic, such as AY.20.1. Molecular surveillance informed the implementation of public health measures and contributed to reduced cases and mortality, however further areas for improvement have been identified for monitoring and managing future pandemics.